Mr. Nissim Bracha has been Chief Executive Officer at Together Pharma Ltd. and serves as its Director since May 2, 2018 and also served as its Partner.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Nissim Bracha	CEO & Director	6.3yrs	₪420.00k	22.27% ₪ 11.6m
Hadar Ron	Independent Director	5.4yrs	데이터 없음	데이터 없음
Irit Ben Ami	Independent Director	8.3yrs	데이터 없음	데이터 없음
Oren Ariel	Member of Advisory Board	no data	데이터 없음	데이터 없음
Tal Elyashiv	Member of Advisory Board	no data	데이터 없음	데이터 없음
Eli Levi	Member of Advisory Board	no data	데이터 없음	데이터 없음
Ronen Samucha	Member of Advisory Board	no data	데이터 없음	데이터 없음
Isaac Edry	Member of Advisory Board	no data	데이터 없음	데이터 없음
Yochanan Danino	Chairman of the Board	5.6yrs	₪432.00k	0.29% ₪ 151.7k
Nir Sosinsky	Director	6.3yrs	₪420.00k	16.63% ₪ 8.7m
Guy Attia	Director	6.3yrs	₪420.00k	22.7% ₪ 11.9m
Haim Yosefi	Independent Director	3.9yrs	데이터 없음	데이터 없음

6.3yrs

평균 재임 기간

63yo

평균 연령

경험이 풍부한 이사회: TGTR 의 이사회는 경험(평균 재직 기간 6.3 년)으로 간주됩니다.

Together Pharma 관리

관리 기준 확인 3/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Is Together Pharma (TLV:TGTR) A Risky Investment?

New major risk - Revenue and earnings growth

Investors Holding Back On Together Pharma Ltd (TLV:TGTR)

New major risk - Shareholder dilution

Together Pharma (TLV:TGTR) Is Achieving High Returns On Its Capital

Further Upside For Together Pharma Ltd (TLV:TGTR) Shares Could Introduce Price Risks After 49% Bounce

Full year 2023 earnings released: ₪0.49 loss per share (vs ₪4.15 loss in FY 2022)

New minor risk - Financial data availability

A Piece Of The Puzzle Missing From Together Pharma Ltd's (TLV:TGTR) Share Price

Returns At Together Pharma (TLV:TGTR) Are On The Way Up

Together Pharma (TLV:TGTR) Has A Somewhat Strained Balance Sheet

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

Together Pharma Ltd's (TLV:TGTR) 35% Jump Shows Its Popularity With Investors

New minor risk - Share price stability

Less than half of directors are independent

First half 2022 earnings released: ₪0.19 loss per share (vs ₪0.082 loss in 1H 2021)

Is Together Pharma (TLV:TGTR) Using Debt Sensibly?

Less than half of directors are independent

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

Together Pharma (TLV:TGTR) Is Looking To Continue Growing Its Returns On Capital

Second quarter 2021 earnings released: ₪0.057 loss per share (vs ₪0.091 profit in 2Q 2020)

Is Together Pharma (TLV:TGTR) Using Too Much Debt?

Investor sentiment improved over the past week

Together Pharma (TLV:TGTR) Might Have The Makings Of A Multi-Bagger

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Here's Why Together Pharma (TLV:TGTR) Has A Meaningful Debt Burden

New 90-day low: ₪1.91

New 90-day low: ₪2.09

New 90-day low: ₪2.44

Can Together Pharma (TLV:TGTR) Continue To Grow Its Returns On Capital?

New 90-day high - ₪3.03

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간

평균 연령